Lv34
308 积分 2026-01-13 加入
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial
14天前
已完结
Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation
14天前
已完结
Spatiotemporally Controlled Co-Treatment of Lung Cancer and Pulmonary Immune-Related Adverse Events by Inhalable Albumin-Chaperoned Ultrathin MnO2 Nanosheets
14天前
已完结
Idiopathic pulmonary fibrosis: state of the art for 2023
14天前
已完结
Redox-activatable inhalable mucoadhesive proteinic nanotherapeutics for targeted treatment of lung cancer
1个月前
已完结
A pH-responsive polycarbonate nanoplatform enables sequential drug release for enhanced apoptotic cascade synergy in non-small cell lung cancer therapy
1个月前
已完结
Inhaled multilevel size-tunable, charge-reversible and mucus-traversing composite microspheres as trojan horse: Enhancing lung deposition and tumor penetration
1个月前
已完结
Targeting HMGB1 modulates cancer-associated fibroblasts and enhances radiotherapy in lung adenocarcinoma
1个月前
已完结
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial
1个月前
已完结
Drug-induced interstitial lung disease
1个月前
已完结
皖公网安备34019202002308
